Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuhiro Miki

Showing results (101-110 of 230) with videos related to

Pageof 23
Sort By:
Cancer Medicine|December 15, 2021
B7-1 and programmed cell death-ligand 1 in primary and lymph node metastasis lesions of non-small cell lung carcinomaTakehiro Yamada, Yasuhiro Miki, Miho Suzuki, et al.
International Journal of Molecular Sciences|August 27, 2021
EphB4 as a Novel Target for the EGFR-Independent Suppressive Effects of Osimertinib on Cell Cycle Progression in Non-Small Cell Lung CancerRen Nanamiya, Ryoko Saito-Koyama, Yasuhiro Miki, et al.
Life Sciences|September 18, 2012
Co-expression of estrogen receptor beta and aromatase in Japanese lung cancer patients: gender-dependent clinical outcomeMohit Kumar Verma, Yasuhiro Miki, Keiko Abe, et al.
Cellular Oncology (Dordrecht, Netherlands)|September 24, 2018
S100P and Ezrin promote trans-endothelial migration of triple negative breast cancer cellsKyoko Kikuchi, Keely May McNamara, Yasuhiro Miki, et al.
Pathology, Research and Practice|June 8, 2024
Toll-like receptor (TLR) 4 is a potent prognostic factor in prostate cancer associated with proliferation and invasionIku Takahashi, Kiyoshi Takagi, Mio Yamaguchi-Tanaka, et al.
Cancer Science|August 5, 2010
Novel classification based on immunohistochemistry combined with hierarchical clustering analysis in non-functioning neuroendocrine tumor patientsShinya Iida, Yasuhiro Miki, Katsuhiko Ono, et al.
Journal of Translational Medicine|July 11, 2013
Intratumoral localization and activity of 17β-hydroxysteroid dehydrogenase type 1 in non-small cell lung cancer: a potent prognostic factorMohit K Verma, Yasuhiro Miki, Keiko Abe, et al.
Hormones & Cancer|January 5, 2013
BUB1 immunolocalization in breast carcinoma: its nuclear localization as a potent prognostic factor of the patientsKiyoshi Takagi, Yasuhiro Miki, Yukiko Shibahara, et al.
Molecular and Cellular Endocrinology|December 6, 2014
The role of 5α-reductase type 1 associated with intratumoral dihydrotestosterone concentrations in human endometrial carcinomaSota Tanaka, Yasuhiro Miki, Chiaki Hashimoto, et al.
Cancer Medicine|December 11, 2020
Suppression of tumor immune microenvironment via microRNA-1 after epidermal growth factor receptor-tyrosine kinase inhibitor resistance acquirement in lung adenocarcinomaSachiko Kawana, Ryoko Saito, Yasuhiro Miki, et al.
Pageof 23

Showing results (101-110 of 230) with videos related to

Sort By:
Pageof 23
Cancer Medicine|December 15, 2021
B7-1 and programmed cell death-ligand 1 in primary and lymph node metastasis lesions of non-small cell lung carcinomaTakehiro Yamada, Yasuhiro Miki, Miho Suzuki, et al.
International Journal of Molecular Sciences|August 27, 2021
EphB4 as a Novel Target for the EGFR-Independent Suppressive Effects of Osimertinib on Cell Cycle Progression in Non-Small Cell Lung CancerRen Nanamiya, Ryoko Saito-Koyama, Yasuhiro Miki, et al.
Life Sciences|September 18, 2012
Co-expression of estrogen receptor beta and aromatase in Japanese lung cancer patients: gender-dependent clinical outcomeMohit Kumar Verma, Yasuhiro Miki, Keiko Abe, et al.
Cellular Oncology (Dordrecht, Netherlands)|September 24, 2018
S100P and Ezrin promote trans-endothelial migration of triple negative breast cancer cellsKyoko Kikuchi, Keely May McNamara, Yasuhiro Miki, et al.
Pathology, Research and Practice|June 8, 2024
Toll-like receptor (TLR) 4 is a potent prognostic factor in prostate cancer associated with proliferation and invasionIku Takahashi, Kiyoshi Takagi, Mio Yamaguchi-Tanaka, et al.
Cancer Science|August 5, 2010
Novel classification based on immunohistochemistry combined with hierarchical clustering analysis in non-functioning neuroendocrine tumor patientsShinya Iida, Yasuhiro Miki, Katsuhiko Ono, et al.
Journal of Translational Medicine|July 11, 2013
Intratumoral localization and activity of 17β-hydroxysteroid dehydrogenase type 1 in non-small cell lung cancer: a potent prognostic factorMohit K Verma, Yasuhiro Miki, Keiko Abe, et al.
Hormones & Cancer|January 5, 2013
BUB1 immunolocalization in breast carcinoma: its nuclear localization as a potent prognostic factor of the patientsKiyoshi Takagi, Yasuhiro Miki, Yukiko Shibahara, et al.
Molecular and Cellular Endocrinology|December 6, 2014
The role of 5α-reductase type 1 associated with intratumoral dihydrotestosterone concentrations in human endometrial carcinomaSota Tanaka, Yasuhiro Miki, Chiaki Hashimoto, et al.
Cancer Medicine|December 11, 2020
Suppression of tumor immune microenvironment via microRNA-1 after epidermal growth factor receptor-tyrosine kinase inhibitor resistance acquirement in lung adenocarcinomaSachiko Kawana, Ryoko Saito, Yasuhiro Miki, et al.
Pageof 23